Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3891475rdf:typepubmed:Citationlld:pubmed
pubmed-article:3891475lifeskim:mentionsumls-concept:C0007776lld:lifeskim
pubmed-article:3891475lifeskim:mentionsumls-concept:C0022655lld:lifeskim
pubmed-article:3891475lifeskim:mentionsumls-concept:C0001613lld:lifeskim
pubmed-article:3891475lifeskim:mentionsumls-concept:C0020615lld:lifeskim
pubmed-article:3891475lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:3891475lifeskim:mentionsumls-concept:C0868945lld:lifeskim
pubmed-article:3891475lifeskim:mentionsumls-concept:C0439828lld:lifeskim
pubmed-article:3891475pubmed:issue7lld:pubmed
pubmed-article:3891475pubmed:dateCreated1985-8-2lld:pubmed
pubmed-article:3891475pubmed:abstractTextCortical function during insulin-induced hypoglycemia was studied in 14 normal controls and 12 type I diabetic patients by measuring the reaction time to a visual stimulus. Each subject was studied on two occasions, during insulin-induced hypoglycemia and under euglycemic conditions. The mean reaction time during euglycemic conditions was 260 +/- 6 ms in the controls and 309 +/- 11 ms in the diabetic subjects (P less than 0.001) and did not change significantly over a 2-h period. Intravenous (i.v.) insulin administration to both groups of subjects resulted in similar reductions in glucose concentrations, which were maintained below 50 mg/dl for at least 30 min. Under these conditions, the reaction time increased significantly (mean increase 104 +/- 37 ms [P less than 0.02] in the controls and 75 +/- 28 ms [P less than 0.02] in the diabetic subjects). However, significant variability in responsiveness was observed in individual subjects. Three of the 14 controls and 4 of the 12 diabetic subjects showed no significant change in reaction time during hypoglycemia, while the remainder demonstrated significant increases. Individual differences were not correlated with severity or duration of hypoglycemia or counterregulatory hormone responses. The maximum increase in reaction time occurred as long as 60 min after the nadir glucose and returned to baseline 10-40 min after normalization (greater than 60 mg/dl) of the plasma glucose level. Subjective awareness of hypoglycemia was unrelated to the change in reaction time.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:3891475pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3891475pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3891475pubmed:languageenglld:pubmed
pubmed-article:3891475pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3891475pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3891475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3891475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3891475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3891475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3891475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3891475pubmed:statusMEDLINElld:pubmed
pubmed-article:3891475pubmed:monthJullld:pubmed
pubmed-article:3891475pubmed:issn0012-1797lld:pubmed
pubmed-article:3891475pubmed:authorpubmed-author:CohenR MRMlld:pubmed
pubmed-article:3891475pubmed:authorpubmed-author:LevyJJlld:pubmed
pubmed-article:3891475pubmed:authorpubmed-author:PolonskyK SKSlld:pubmed
pubmed-article:3891475pubmed:authorpubmed-author:HeroldK CKClld:pubmed
pubmed-article:3891475pubmed:authorpubmed-author:DouglasFFlld:pubmed
pubmed-article:3891475pubmed:issnTypePrintlld:pubmed
pubmed-article:3891475pubmed:volume34lld:pubmed
pubmed-article:3891475pubmed:ownerNLMlld:pubmed
pubmed-article:3891475pubmed:authorsCompleteYlld:pubmed
pubmed-article:3891475pubmed:pagination677-85lld:pubmed
pubmed-article:3891475pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:meshHeadingpubmed-meshheading:3891475-...lld:pubmed
pubmed-article:3891475pubmed:year1985lld:pubmed
pubmed-article:3891475pubmed:articleTitleVariable deterioration in cortical function during insulin-induced hypoglycemia.lld:pubmed
pubmed-article:3891475pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3891475pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3891475pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3891475lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3891475lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3891475lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3891475lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3891475lld:pubmed